MediWound Ltd. (MDWD) — Financial statements
Income statement, balance sheet, and cash flow for MediWound Ltd. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 17↓16.1% | 20↑8.2% | 19↓29.5% | 26↑11.5% | 24 | |
| Cost of Revenue | 14↓25.7% | 18↑17.2% | 16↑11.0% | 14↓9.3% | 16 | |
| Gross Profit | 3↑82.7% | 2↓39.6% | 3↓76.1% | 12↑51.4% | 8 | |
| Operating Expenses | ||||||
| R&D Expenses | 14↑73.5% | 8↑16.7% | 7↓26.4% | 10↓3.0% | 10 | |
| General & Administrative Expenses | 10 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 4 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 14↑7.9% | 13↑13.5% | 11↑9.7% | 10↑9.7% | 9 | |
| Other Expenses | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 29↑34.8% | 21↑14.7% | 18↓7.7% | 20↑3.2% | 19 | |
| Total Costs & Expenses | 42↑6.6% | 40↑15.8% | 34↑0.1% | 34↓2.4% | 35 | |
| Operating Results | ||||||
| Operating Income | -25↓30.4% | -19↓25.0% | -16↓102.3% | -8↑31.7% | -11 | |
| Depreciation & Amortization | 2↑25.4% | 1↑13.8% | 1↑2.5% | 1↑2.7% | 1 | |
| EBITDA | -21↑23.6% | -28↓474.7% | -5↑72.9% | -18↓49.3% | -12 | |
| EBIT | -23↑21.2% | -30↓377.8% | -6↑68.0% | -19↓44.9% | -13 | |
| Interest & Other Income | ||||||
| Net Interest Income | 1↓19.6% | 1↓25.9% | 2↑1757.4% | 0.11↑169.2% | -0.16 | |
| Interest Income | 2↓9.2% | 2↓12.5% | 2↑767.0% | 0.27↑2354.5% | 0.01 | |
| Interest Expense | 0.66↑18.2% | 0.56↑67.5% | 0.34↑106.8% | 0.16↓3.0% | 0.17 | |
| Non-Operating Income | -2↓119.1% | 10↑209.8% | -9↓179.5% | 12↑447.7% | 2 | |
| Other Income / Expenses | 2↑114.6% | -11↓220.2% | 9↑175.6% | -12↓415.0% | -2 | |
| Income Before Tax | -24↑21.4% | -30↓361.8% | -7↑66.5% | -20↓44.3% | -14 | |
| Income Tax Expense | 0.17↑177.0% | 0.06↓67.0% | 0.19↑137.2% | 0.08↑188.9% | 0.03 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -24↑21.0% | -30↓350.0% | -7↑65.7% | -20↓44.6% | -14 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -24↑21.0% | -30↓350.0% | -7↑65.7% | -20↓44.6% | -14 | |
| Bottom-Line Net Income | -24↑21.0% | -30↓350.0% | -7↑65.7% | -20↓44.6% | -14 | |
| EPS (Basic) | -2.10↑30.7% | -3.03↓304.0% | -0.75↑80.9% | -3.93↓12.9% | -3.48 | |
| EPS (Diluted) | -2.10↑30.7% | -3.03↓304.0% | -0.75↑80.9% | -3.93↓12.9% | -3.48 | |
| Weighted Average Shares | 11↑14.2% | 10↑10.5% | 9↑80.7% | 5↑28.1% | 4 | |
| Weighted Average Diluted Shares | 11↑14.2% | 10↑10.5% | 9↑80.7% | 5↑28.1% | 4 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.